4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-19-000340
CHIEF FINANCIAL OFFICER bought 6,900 shares at $3.85 ($26,565)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FARR KEVIN M CHIEF FINANCIAL OFFICER | 2019-03-15 | Purchase | +6,900 | $3.85 | $26,565 | 36,625 | D: show line 1 in the form |
| Open-market purchases · 6,900 sh · avg $3.85 · $26,565 | |||||||
Loading xslF345X03/form4-03152019_050347.xml…